ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study

Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy

(2016) Peter Ka-Fung Chiu et al.   ANNALS OF SURGICAL ONCOLOGY

Active surveillance for prostate cancer: a narrative review of clinical guidelines

(2016) Sophie M. Bruinsma et al.   Nature Reviews Urology

Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men

(2016) Zeyad R. Schwen et al.   UROLOGY

Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification

(2015) Stacy Loeb et al.   EUROPEAN UROLOGY

Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis

(2015) R Guo et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Multiparametric Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Targeted Biopsy of the Prostate: Preliminary Results of a Prospective Single-Centre Study

(2015) Daniel Junker et al.   UROLOGIA INTERNATIONALIS

Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy

(2015) Francesco Cantiello et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance

(2015) Isabel Heidegger et al.   PLoS One

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program

(2015) Isabel Heidegger et al.   PLoS One

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

(2013) James Thompson et al.   BJU INTERNATIONAL

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

[-2]proPSA is an early marker for prostate cancer aggressiveness

(2013) I Heidegger et al.   PROSTATE CANCER AND PROSTATIC DISEASES

From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

(2012) Satoshi Hori et al.   BJU INTERNATIONAL

Association of [−2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer

(2012) Jeffrey J. Tosoian et al.   JOURNAL OF UROLOGY

Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration

(2012) Stacy Loeb et al.   JOURNAL OF UROLOGY

A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness

(2010) L. J. Sokoll et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Is PSA velocity useful?

(2009) Stacy Loeb   Nature Reviews Urology

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

(2008) Georg Bartsch et al.   BJU INTERNATIONAL